Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
national blog main
boston blog main
boston top stories
cymabay therapeutics
intercept pharmaceuticals
national top stories
new york
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
primary biliary cholangitis (pbc)
akero therapeutics
allergan
amgen
bausch health
boston
complete response letter
crl
dry eye
elafibrinor
fibrosis
genfit
gilead sciences
inflammation
kala pharma
mark pruzanski
novartis
san francisco blog main
san francisco top stories
seladelpar
takeda pharmaeutical
todd bazemore
What
drug
3
×
fda
pharmaceuticals
3
×
rejected
3
×
data
intercept
liver
approval
asks
august
based
candidate
comes
commonly
cutting
decision
developed
disease
disorder
dry
eye
fatty
filing
fourth
headcount
months
nash
new
nonalcoholic
pharma
pharma’s
readied
reeling
referred
regulatory
rejection
shot
slashes
steatohepatitis
treat
Language
unset
Current search:
rejected
×
fda
×
drug
×
pharmaceuticals
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}